September 2023 BCOP Test - Ampullary Adenocarcinoma: Overview of Subtypes and Treatments |
|
02/28/2023 - 12:00am to 09/13/2024 - 11:59pm |
Supporting Cancer Patients with Post-traumatic Stress Disorder (PTSD) |
0.50 |
08/04/2022 - 12:00am to 08/04/2024 - 12:00am |
Supporting Cancer Patients with Substance Use Disorder |
0.50 |
08/04/2022 - 12:00am to 08/04/2024 - 12:00am |
Supportive Oncology Care - How to Incorporate Into Your Practice |
0.50 |
08/04/2022 - 12:00am to 08/04/2024 - 12:00am |
Tackling Inequities in Multiple Myeloma: Practical Steps for Improving Access and Quality of Care |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
The Evolving Landscape in CLL/SLL: Best Practice Clinical Applications of Current Evidence and New Guideline Recommendations |
1.75 |
07/21/2023 - 12:00am to 07/21/2024 - 12:00am |
Unlocking the Potential of Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC: The Role of Checkpoint Inhibitors |
1.75 |
08/09/2023 - 12:00am to 08/09/2024 - 12:00am |
Updates in the Management of Mantle Cell Lymphoma: Is There Still a Role for Transplant? |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Updates in the Management of Myelofibrosis |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
What Drives Reimbursement for Biomarker Testing? |
1.25 |
06/15/2023 - 12:00am to 06/15/2024 - 12:00am |
What is Biomarker Testing, and Why Is It Important? |
1.00 |
06/15/2023 - 12:00am to 06/15/2024 - 12:00am |